Faculty members

Faculty members

Mark Jit

Mark’s research focuses on epidemiological and economic modelling of vaccines to support evidence-based public health decision making. He has published work covering a range of antigens for current and pipeline vaccines including measles, HPV, pneumococcus, rotavirus, influenza, dengue, EV71 and RSV, as well as methodological papers advancing the ways vaccines are evaluated.

Selected papers

Katherine Atkins

I am a mathematical modeller have worked at LSHTM as an Assistant Professor of Infectious Disease Modelling since 2014. My work focuses on using vaccines to controlling antibiotic resistance and understanding the determinants of HIV acquisition.

Rosalind Eggo

My focus is on severe outcomes following respiratory virus infections. I also work on vaccination strategies for Ebola virus disease.

Albert Jan van Hoek

Petra Klepac

As a part of Vaccine Impact Modelling Consortium, I mainly focus on estimating the impact of measles and rotavirus vaccines. In addition, I look at the effects of changing demography and seasonality on the dynamics of these two infectious diseases, and how better to control them.

Selected papers

Kaja Abbas

My research focus is epidemiological and economic modelling of infectious diseases at the interface of infectious disease system dynamics and public health systems research. The research goal is to generate valuable findings that can assist policy makers locally and globally in choosing optimal public health interventions, including optimal vaccine program investments to reduce infectious disease burden effectively, efficiently and equitably.

Selected papers

Stefan Flasche

Mathematical modelling, vaccines, pneumococci

Artemis Koukounari

I am an Assistant Professor in Epidemiology in the Faculty of Epidemiology and Public Health (Department of Infectious Disease Epidemiology), London School of Hygiene and Tropical Medicine.

I am involved in the planning of cohort re-enrolment for long term outcomes of Group B Streptococcus (GBS) disease in infancy, specifically neurodevelopmental impairment, as well as other health and socio-economic consequences. Currently I am also investigating statistical methods for data pooling. Such work will contribute to the development of a value proposition for GBS maternal immunization with WHO.
More broadly I am using statistical modelling to inform public health decisions about vaccination and other control measures for infectious diseases.

Comments are closed.